Red Spruce Capital LLC purchased a new position in shares of Xylem Inc (NYSE:XYL) in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 5,723 shares of the industrial products company’s stock, valued at approximately $451,000.

A number of other institutional investors also recently made changes to their positions in XYL. City Holding Co. boosted its position in Xylem by 116.7% in the third quarter. City Holding Co. now owns 325 shares of the industrial products company’s stock worth $26,000 after purchasing an additional 175 shares during the last quarter. Winthrop Partners WNY LLC purchased a new position in Xylem in the third quarter worth $32,000. Valeo Financial Advisors LLC boosted its position in Xylem by 500.0% in the third quarter. Valeo Financial Advisors LLC now owns 420 shares of the industrial products company’s stock worth $33,000 after purchasing an additional 350 shares during the last quarter. Candriam Luxembourg S.C.A. boosted its position in Xylem by 10.8% in the third quarter. Candriam Luxembourg S.C.A. now owns 474,113 shares of the industrial products company’s stock worth $38,000 after purchasing an additional 46,293 shares during the last quarter. Finally, Doyle Wealth Management purchased a new position in Xylem in the second quarter worth $46,000. Institutional investors and hedge funds own 84.64% of the company’s stock.

Shares of NYSE XYL opened at $82.45 on Thursday. Xylem Inc has a one year low of $67.71 and a one year high of $85.67. The company has a debt-to-equity ratio of 0.70, a current ratio of 1.55 and a quick ratio of 1.15. The business’s fifty day moving average price is $78.29 and its 200-day moving average price is $78.52. The stock has a market capitalization of $14.65 billion, a PE ratio of 28.63, a P/E/G ratio of 1.48 and a beta of 1.16.

Xylem (NYSE:XYL) last issued its quarterly earnings results on Thursday, October 31st. The industrial products company reported $0.82 EPS for the quarter, meeting analysts’ consensus estimates of $0.82. Xylem had a return on equity of 19.14% and a net margin of 9.65%. The firm had revenue of $1.30 billion for the quarter, compared to analysts’ expectations of $1.33 billion. During the same quarter in the prior year, the firm earned $0.77 EPS. The business’s revenue for the quarter was up .7% compared to the same quarter last year. As a group, equities analysts expect that Xylem Inc will post 3.02 EPS for the current fiscal year.

In related news, SVP Kenneth Napolitano sold 5,000 shares of the business’s stock in a transaction on Monday, December 9th. The stock was sold at an average price of $75.09, for a total transaction of $375,450.00. Following the sale, the senior vice president now directly owns 46,228 shares in the company, valued at approximately $3,471,260.52. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, Director Markos I. Tambakeras sold 2,860 shares of the business’s stock in a transaction on Tuesday, November 5th. The shares were sold at an average price of $78.95, for a total value of $225,797.00. Following the sale, the director now owns 43,530 shares in the company, valued at $3,436,693.50. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 13,080 shares of company stock worth $1,016,717. 0.85% of the stock is currently owned by corporate insiders.

Several research analysts have weighed in on the company. Jefferies Financial Group cut Xylem from a “buy” rating to a “hold” rating and cut their price objective for the stock from $90.00 to $70.00 in a research report on Thursday, December 5th. Citigroup assumed coverage on Xylem in a research report on Tuesday, December 17th. They issued a “neutral” rating and a $84.00 price objective on the stock. Cfra cut Xylem from a “buy” rating to a “hold” rating in a research report on Friday, November 1st. Zacks Investment Research cut Xylem from a “hold” rating to a “sell” rating and set a $82.00 price objective on the stock. in a research report on Monday, October 14th. Finally, Seaport Global Securities cut Xylem from a “buy” rating to a “neutral” rating in a research report on Monday, November 4th. One equities research analyst has rated the stock with a sell rating, seven have given a hold rating and six have issued a buy rating to the company. The stock presently has an average rating of “Hold” and an average target price of $80.50.

About Xylem

Xylem Inc engages in the design, manufacture, and servicing of engineered products and solutions for the water and wastewater applications. It operates in three segments: Water Infrastructure, Applied Water, and Measurement & Control Solutions. The Water Infrastructure segment offers various products, including water and wastewater pumps; controls and systems; filtration, disinfection, and biological treatment equipment; and mobile dewatering equipment under the Flygt, Godwin, Wedeco, Sanitaire, and Leopold names for the transportation and treatment of water.

Further Reading: Why are percentage gainers important?

Institutional Ownership by Quarter for Xylem (NYSE:XYL)

Receive News & Ratings for Xylem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Xylem and related companies with MarketBeat.com's FREE daily email newsletter.